CRISPR Therapeutics AG
Long

4 hour bullish divergence

299
It was pointed out to me earlier that the last time I posted was back in May so I thought I’d pull my finger out and share this one.

The company has developed a cure for sickle cell disease, by gene editing, this disease is seriously debilitating and affects millions of people of African descent, this is a game changer for people with this disease.

The company are still loss making but this groundbreaking technology has the potential to cure other previously incurable diseases.

Cathie Wood has been accumulating shares in her Ark fund, it has huge potential, picked up a few shares earlier today

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.